(Chest. 2008; 133:0b)
© 2008 American College of Chest Physicians
Endorsements and Disclaimer
 |
Endorsements
|
|---|
These guidelines have been endorsed by the American College of Clinical Pharmacy and the American Society of Health-System Pharmacists.
|
ACCP Guideline Disclaimer
|
|---|
The evidence-based practice guidelines published by The American College of Chest Physicians ("ACCP") incorporate data obtained from a comprehensive literature review of the most recent studies then available. Guidelines are intended for general information only, are not medical advice, and do not replace professional medical care and physician advice, which always should be sought for any specific condition. Furthermore, guidelines may not be complete or accurate because new studies that may have become available late in the process of guideline development may not be incorporated into any particular guideline before it is disseminated. The ACCP and its officers, regents, governors, executive committee, members, and employees (the "ACCP Parties") disclaim all liability for the accuracy or completeness of a guideline, and disclaim all warranties, express or implied. Guideline users always are urged to seek out newer information that might impact the diagnostic and treatment recommendations contained within a guideline. The ACCP Parties further disclaim all liability for any damages whatsoever (including, without limitation, direct, indirect, incidental, punitive, or consequential damages) arising out of the use, inability to use, or the results of use of a guideline, any references used in a guideline, or the materials, information, or procedures contained in a guideline, based on any legal theory whatsoever and whether or not there was advice of the possibility of such damages.
Through a comprehensive and systematic literature review, the ACCP’s evidence-based clinical practice guidelines incorporate data from the existing literature. This literature meets the prespecified inclusion criteria for the clinical research question, which the ACCP considers, at the time of publication, to be the best evidence available for general clinical information purposes. This evidence is of varying quality from original studies of varying methodological rigor. The ACCP recommends that performance measures for quality improvement, performance-based reimbursement, and public reporting purposes should be based on recommendations that are graded 1A or 1B, according to the ACCP Grading System.1 However, all recommendations that are graded 1A or 1B should not necessarily be developed into such performance measures, and each one should be analyzed individually for feasibility, usability, scientific importance, practicality, and applicability. (The first four are National Quality Forum criteria; the last is an ACCP additional criterion.) Performance measures developers should exercise caution in basing measures on 1B recommendations. Recommendations that are graded 1C, 2A, 2B, and 2C, according to the ACCP Grading System should generally not be used as performance measures for quality improvement, performance-based reimbursement, and public reporting purposes.
|
Acknowledgements
|
|---|
The Executive Committee of the panel and the ACCP would like to thank Al Lever, MA, FCCP(Hon) for his guidance and encouragement in our efforts in raising the quality of the Guidelines to higher standards. We would also like to acknowledge the editorial assistance of Emma Lapinski, as well as Amy Reynaldo, Carla Hess, and Amy Rosenstein.
|
References
|
|---|
- Guyatt, G, Gutterman, D, Baumann, MH, et al (2006) Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians task force. CHEST 129,174-181[CrossRef][ISI][Medline]
TOP
Endorsements
ACCP Guideline Disclaimer
